Point-of-care testing with Xpert HPV for single-visit, screen-and-treat for cervical cancer prevention: a demonstration study in South Africa
Abstract Human papillomavirus (HPV)-based screen-and-treat (SAT) is recommended but implementation presents operational challenges. We implemented HPV-SAT at a research site in Khayelitsha, South Africa, screening 3062 women aged 30–65 years (44% women living with HIV [WHIV]). All were screened usin...
Main Authors: | Lynette Denny, Rakiya Saidu, Rosalind Boa, Nomonde Mbatani, Delivette Castor, Jennifer Moodley, Louise Kuhn |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-09-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-43467-2 |
Similar Items
-
Validation of intra- and inter-laboratory reproducibility of the Xpert HPV assay according to the international guidelines for cervical cancer screening
by: Ajmal Akbari, et al.
Published: (2018-10-01) -
Evaluating operational parameters of the careHPV, GeneXpert, AmpFire, and MA-6000 HPV systems for cervical precancer screening: Experience from Battor, Ghana.
by: Kofi Effah, et al.
Published: (2023-01-01) -
Comparison of the AmpFire® Multiplex HPV Assay to the Xpert® HPV Assay for detection of human papillomavirus and cervical disease in women with human immunodeficiency virus: a pragmatic performance evaluation
by: Sikhulile Moyo, et al.
Published: (2023-05-01) -
Challenges with the use of Xpert HPV as a screening tool for oral HPV among people living with HIV (PLHIV): experiences from Pune, India
by: Abigail Admase, et al.
Published: (2023-04-01) -
HPV-associated cervicitis
by: Margarita V. Andreeva, et al.
Published: (2023-01-01)